Biotech Industry Leaders and Exciting Start-ups to Forge Partnerships at First Ever BIO-Europe Spring Partnering Conference in Milan, March 5-7, 2007
Unique opportunity for international press to interact directly with world’s hottest biotech firms
San Diego, CA, and Munich, Germany, February 7, 2007: On Monday, March 5, the first-ever BIO-Europe Spring will open its doors at the Milano Convention Center (MIC) in Italy. The three day conference (March 5-7) promises to be exciting as deal- and decision makers from across the globe meet at the pre-eminent springtime partnering conference for the biotechnology industry.
Like its conference counterpart, BIO-Europe, which is held in the Autumn, BIO-Europe Spring will be an important focal point for companies seeking to identify new business opportunities and strike deals to drive future business. The conference, organized by EBD Group, will feature many notable industry leaders such as Rob Wills, VP of Alliance Management at Johnson & Johnson; Judith Hills, VP of Corporate and Business Development for Licensing, Europe, Japan & Asia Pacific, at Bristol-Myers Squibb; and Roger Longman, Managing Partner of Windhover Information. These and other speakers will cover a wide range of trends, issues and technologies that are shaping the industry’s future
The conference will also feature a proprietary online partnering system through which participants can set up individual meetings with potential partners—thus providing an unbeatable opportunity for direct engagement between individuals from all parts the biotechnology value chain.
EBD Group, the organizer of the BIO-Europe Spring and BIO-Europe partnering conferences, expects more than 1,000 attendees to attend the conference—which should become one of the world’s premier international partnering events for biotechnology and the life sciences. Since 1993, EBD Group’s conferences have provided annual partnering fora for networking, sharing research and innovations and striking deals. Today, the BIO-Europe conferences are the largest and most comprehensive international life science partnering events in the world.
Highlights of the BIO-Europe Spring conference sessions include:
- Rethinking the Biotech-Pharma Partnering Model: Will
the whole ever be worth more than the sum of its parts?
- Next Generation Companies: With increasing competition
for late-stage assets, pharmaceutical companies are taking a greater
interest in earlier stage biotech companies. In keeping with
this trend, some of the most exciting early-stage players of the
biotech industry will make their pitches to the conference’s
elite audience.
- Pink Biotech, The Convergence of White and Red Biotech: New
enabling technologies are transforming the industry and cost-advantages
linked to disruptive technologies are already a reality. BIO-Europe
Spring will explore how the convergence of White and Red biotech
will play a key role in helping both early and late-stage companies
overcome industry challenges.
- Future of Mid-sized Pharma: Globalization is profoundly
affecting the biotechnology industry-- and especially mid-sized pharma
companies. This session explores the unique opportunities and challenges
confronting mid-sized firms and discusses optimal ways to navigate
the globalization trend.
Partnering System Goes Live:
The web-based conference partnering system is now live and registered
attendees can access it at www.ebdgroup.com/bioeuropespring/partnering/index.php.
As at all EBD Group conferences, BIO-Europe Spring leverages the
organizer’s proprietary state-of-the-art web-based partnering
software platform. The partnering system enables all participants
to quickly query a comprehensive database in order to identify and
engage with many potential partners during the conference. The partnering
system also allows journalists to arrange meetings and interviews
in advance of the conference. Two-hundred booths will be available
for one-on-one meetings. In addition, a quiet interview room
in the BIO-Europe Europe press office can be booked on site. Delegates’ meeting
schedules will be made available on personal log-in pages on the
BIO-Europe Spring website in the days prior to the conference.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
BD Group's conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- EuroMedtech™, EBD Group's partnering event for the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- Partnering for Global Impact®, a new partnering conference providing an innovative forum to partner, identify and generate social and philanthropic investment and funding opportunities
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences at industry events.
Outside of the conference format, EBD Group's consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com or contact:
Constantine Theodoropulos
EBD Group
+1 617 816 4637
ctheodoropulos@ebdgroup.com







